The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading higher by 166 points at 24,718, indicating that the domestic benchmark indices are likely to make a positive start on Tuesday.

Earlier on Monday, 11 August, Domestic benchmark indices S&P BSE Sensex surged by 746 points or 0.93%, and settled at 80,606 while the Nifty50 traded 0.91% higher or 221 points, closing at 24,585.

Here are some stocks that are likely to remain in focus on 12 August.

Quarterly Results Today: Bharat Dynamics, National Securities Depository (NSDL), Zydus Lifesciences, Oil and Natural Gas Corporation, Hindalco Industries, Apollo Hospitals Enterprise, FSN E-Commerce Ventures Nykaa, Honasa Consumer, Alkem Laboratories, Dr Agarwals Eye Hospital, EMS, Hindustan Aeronautics, Jindal Steel & Power, Abbott India, Dr Agarwals Health Care, Karnataka Bank, Natco Pharma, Nazara Technologies, Rail Vikas Nigam, Senco Gold, Suzlon Energy, NHPC, NMDC, Oil India, and VA Tech Wabag are some of the prominent companies set to announce their quarterly earnings for April-June. 

IHCL: Indian Hotels Company (IHCL), part of the Tata Group, will take controlling stakes in ANK Hotels Private Limited and Pride Hospitality Private Limited. The combined transaction, valued at up to Rs 204 crore, will see IHCL acquire around 51% of ANK Hotels for up to Rs 110 crore.

Adani Shares: Adani Defence & Aerospace, in partnership with Prime Aero, signed a deal to fully acquire Indamer Technics Private Limited, one of India’s leading private aircraft maintenance, repair and overhaul (MRO) companies. Horizon Aero Solutions, a 50:50 joint venture between Adani Defence and Prime Aero, led by Prajay Patel of Indamer Technics who will carry out the acquisition. 

Pfizer: Pfizer launched its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) in India to immunise adults against 20 serotypes responsible for most invasive and non-invasive pneumococcal diseases.

Bata India: Bata India’s net profit for Q1FY26 plunged 70% to Rs 52 crore as weather disruptions and weak demand dented sales. Revenue remained flat at Rs 942 crore, but disciplined cost control lifted EBITDA 7.6% to Rs 198.8 crore, improving margins to 21.1%.

Hindalco: Novelis, Hindalco’s US-based subsidiary, reported a 36% drop in net income to $96 million for Q1FY26. Adjusted EBITDA fell 17% to $416 million, but net sales grew 13% to $4.7 billion, driven by higher aluminium prices and a slight rise in shipments.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!